American Society of Hirudotherapy

Administración Nacional de Medicamentos, Alimentos y Tecnología Médica

ANMAT · Argentina · latin america

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Argentina's national administration of drugs, food and medical technology — leech-specific regulatory pathway has not been independently verified by ASH.

Regulatory Profile

Agency type
national regulator
Region
latin america
Country
Argentina
Leech status
unregulated
Last ASH review
2026-05-25

Relevant Regulation Codes

  • Ley 16.463 (Argentine medicines law)
  • ANMAT medical device regulatory framework (Disposiciones)

Prescriber Requirements

  • Argentine medical college-registered MD prescription required
  • Non-physician practitioner scope for hirudotherapy not independently verified by ASH

Supply Chain & GMP

ANMAT product registration if classified as a medical device; Spanish-language labelling.

Import/Export Rules

ANMAT import authorisation plus SENASA (Servicio Nacional de Sanidad y Calidad Agroalimentaria) veterinary clearance for live invertebrates; CITES Appendix II paperwork.

Reimbursement Context

PAMI, obras sociales, and prepagas (private prepaid health plans) coverage for hirudotherapy not independently verified by ASH.

ASH Editorial Notes

ANMAT operates under the Ministry of Health; specific regulatory pathway for medicinal leech use in Argentina has not been independently verified by ASH and should be confirmed with Argentine counsel.

Related Jurisdictions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.